Department of Neurology, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Republic of Korea.
Department of Critical Care Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Transl Stroke Res. 2021 Dec;12(6):968-975. doi: 10.1007/s12975-021-00895-4. Epub 2021 Feb 12.
Glycemic variability (GV) is a risk factor for poor outcomes after ischemic stroke. However, its effect on hemorrhagic transformation after endovascular recanalization therapy (ERT) remains to be elucidated.
Patients with acute ischemic stroke due to large vessel occlusion with successful recanalization after ERT (modified thrombolysis in cerebral infarction 2b or 3) were enrolled between January 2013 and November 2019. Blood glucose level data were obtained during the first 36 h after ERT, and ten GV parameters including time rate (TR) of glucose variation were assessed. The TR of glucose variation reflects the speed of glucose fluctuations over time (mg/dL/hour) during the monitoring period. Symptomatic intracerebral hemorrhage (sICH) and unfavorable outcomes at 3 months after ERT were analyzed. The sICH was defined as parenchymal hematoma type 2 with a neurological deterioration of 4 points or more on the National Institute of Health Stroke Scale. Moreover, a modified Rankin Scale of 3-6 at 3 months was considered an unfavorable outcome.
Among all patients (n = 176; mean age, 69.3 years; 47.7 % female), sICH developed after successful ERT in 16 (9.1%) patients. In addition, 54% (n = 95) patients had an unfavorable outcome at 3 months. Patients with sICH and unfavorable outcome had higher the TR of glucose variation. After adjusting for potential confounders, the TR of glucose (per 1 mg/dL/h increase) variation was independently associated with sICH (odds ratio, 1.17; 95% confidence interval [CI], 1.012-1.343) and 3-month unfavorable outcome (OR 1.14, 95% CI, 1.000-1.297).
Time-related GV during the first 36 h after successful ERT has a stronger correlation with sICH and poor functional outcomes compared to any GV parameters. This suggests that maintaining stable glucose may be an important factor in the prevention of sICH after undergoing successful ERT.
血糖变异性(GV)是缺血性卒中后不良结局的危险因素。然而,其对血管内再通治疗(ERT)后出血转化的影响仍需阐明。
纳入 2013 年 1 月至 2019 年 11 月期间因大血管闭塞性急性缺血性卒中且 ERT 后成功再通的患者(改良脑梗死溶栓治疗 2b 或 3 级)。ERT 后 36 小时内获得血糖水平数据,并评估了包括时间率(TR)在内的 10 个血糖变异参数。血糖变异的 TR 反映了监测期间血糖波动的速度(mg/dL/h)。分析症状性颅内出血(sICH)和 ERT 后 3 个月的不良结局。sICH 定义为 NIHSS 评分增加 4 分或以上的实质血肿 2 型。此外,改良 Rankin 量表评分 3-6 分被认为是 3 个月的不良结局。
在所有患者(n=176;平均年龄 69.3 岁;47.7%为女性)中,16 例(9.1%)患者在 ERT 后发生 sICH。此外,54%(n=95)患者在 3 个月时预后不良。发生 sICH 和预后不良的患者血糖 TR 较高。在调整了潜在混杂因素后,血糖 TR(每 1mg/dL/h 增加)的变化与 sICH(优势比,1.17;95%置信区间 [CI],1.012-1.343)和 3 个月时的不良结局(OR 1.14,95%CI,1.000-1.297)独立相关。
ERT 后 36 小时内与时间相关的血糖变异性与 sICH 和预后不良的相关性比任何血糖变异参数都更强。这表明,在成功接受 ERT 后,维持血糖稳定可能是预防 sICH 的一个重要因素。